AnaptysBio (ANAB) PT Lowered to $56 at Stifel
Tweet Send to a Friend
Stifel analyst Alex Thompson lowered the price target on AnaptysBio (NASDAQ: ANAB) to $56.00 (from $80.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
